CYTOGENESIS LIMITED
Significant control: Prof. Peter Friedl (25–50%), Mark Andre Freyberg (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Cytogenesis Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Cytogenesis Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
CYTOGENESIS LIMITED is an active private limited company (company number 13665458) incorporated on 6 October 2021, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 October 2025, showing net assets of £570k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 1% on the prior period (£576k).
By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).
Ownership and control
- Prof. Peter Friedl
- owns 25–50% of shares
- owns 25–50% of shares
- owns 25–50% of shares
- Mr Mark Andre Freyberg
- owns 25–50% of shares
- Mr Mark Andre Freyberg
- owns 75–100% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 6 October 20215 yrs ago
- Next accounts due
- 31 July 2027in 280 days
- Confirmation statement due
- 20 October 2027in 361 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 October 2025 | £570k | — | — | £12k | — | — | 2 |
| 31 October 2024 | £576k | — | — | £0 | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £570,344 at 31 October 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 21.56
- Incorporated five or more years agoIncorporated 6 October 2021
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 361 days
- Next accounts duein 280 days
- Accounts period endNet assets £570k · micro accounts
- Accounts period endNet assets £576k · micro accounts
- Incorporated
Similar companies in London
- OVLUNA LIMITEDLondon · inc. Oct 2021
- OSHUN LABS LTDLondon · inc. Oct 2021
- NETZERONITROGEN LTDLondon · inc. Oct 2021
- SCIENCE 37 UK LIMITEDLondon · inc. Oct 2021
- SYDERMA LTDLondon · inc. Oct 2021
- CHINESE LIFE SCIENTISTS SOCIETY IN THE UK LIMITEDLondon · inc. Sept 2021
All companies incorporated on 6 October 2021 · in Oct 2021.
Reminders for CYTOGENESIS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.